CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Application of BioFire FilmArray Blood Culture Identification panel for rapid identification of the causative agents of ventilator-associated pneumonia
Authors
M.R. Pulido Moreno-Martínez, P. González-Galán, V. Fernández Cuenca, F. Pascual, Á. Garnacho-Montero, J. Antonelli, M. Dimopoulos, G. Lepe, J.A. McConnell, M.J. Cisneros, J.M. Ramírez Gallmore, P. Bonastre, J. Montejo González, J.C. Díaz-Miguel, R.O. García, A.E. Crespo, R.Z. Camerino, R.S. Gutiérrez, M.H. Alvarez-Rocha, L. Sanchez Garcia, M. Allegue Gallego, J.M. Castellanos Ortega, Á. de la Torre Prados, M.V. Roca, R.F. Cortés, P.V. Armaganidis, A. Serafim Georgopoulos, D. Pneumatikos, L. Nakos, G. Baltopoulos, G. Koutsoukou, A. Zakynthinos, E. Militsa-Bitsani Komnos, A. Pennisi, M. DePascale, G. DiGravio, V. Rocco, M. De Blasi, R. De Gasperi, A. Ranieri- Francesco de Rosa, V.M. De Robertis-Rosalba, E. Guarracino the MagicBullet Working Group
Publication date
1 January 2018
Publisher
Abstract
Objective: To evaluate the ability of the BioFire FilmArray Blood Culture Identification (BCID) panel to rapidly detect pathogens producing late-onset ventilator-associated pneumonia (VAP), a severe infection often produced by Gram-negative bacteria. These microorganisms are frequently multidrug resistant and typically require broad-spectrum empiric treatment. Methods: In the context of an international multicentre clinical trial (MagicBullet), respiratory samples were collected at the time of suspicion of VAP from 165 patients in 32 participating hospitals in Spain, Greece and Italy. Microorganisms were identified using the BCID panel and compared with results obtained by conventional microbiologic techniques. Results: Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae were the most commonly identified species, representing 54.7% (70/128) of microorganisms. The BCID panel showed high global specificity (98.1%; 95% confidence interval, 96–100) and negative predictive values (96.6%) and a global sensitivity and positive predictive value of 78.6% (95% confidence interval, 70–88) and 87.3%, respectively, for these microorganisms. Importantly, the BCID panel provided results in only 1 hour directly from respiratory samples with minimal sample processing times. Conclusions: The BCID panel may have clinical utility in rapidly ruling out microorganisms causing VAP, specifically multidrug-resistant Gram-negative species. This could facilitate the optimization of empiric treatment. © 2018 European Society of Clinical Microbiology and Infectious Disease
Similar works
Full text
Available Versions
Pergamos : Unified Institutional Repository / Digital Library Platform of the National and Kapodistrian University of Athens
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:lib.uoa.gr:uoadl:3106922
Last time updated on 10/02/2023